FDA Approves New Autism Treatment Amid Policy Changes

1 min read
Source: The New York Times
FDA Approves New Autism Treatment Amid Policy Changes
Photo: The New York Times
TL;DR Summary

The FDA unexpectedly approved the old chemotherapy drug leucovorin as a treatment for some individuals with autism, deviating from its usual rigorous review process, which has raised concerns among experts about the potential for hype and the narrowing of the drug's scope.

Share this article

Reading Insights

Total Reads

0

Unique Readers

0

Time Saved

1 min

vs 2 min read

Condensed

82%

23242 words

Want the full story? Read the original article

Read on The New York Times